These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1691925

  • 1. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
    Degrell I, Nagy E.
    Biol Psychiatry; 1990 Apr 15; 27(8):891-6. PubMed ID: 1691925
    [Abstract] [Full Text] [Related]

  • 2. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.
    Johansson B, Roos BE.
    Acta Neurol Scand; 1975 Aug 15; 52(2):137-44. PubMed ID: 1155031
    [Abstract] [Full Text] [Related]

  • 3. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
    Degrell I, Nagy E.
    Biol Psychiatry; 1990 May 15; 27(10):1179-82. PubMed ID: 1692743
    [No Abstract] [Full Text] [Related]

  • 4. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
    Raleigh MJ, Brammer GL, McGuire MT, Pollack DB, Yuwiler A.
    Neuropsychopharmacology; 1992 Dec 15; 7(4):295-304. PubMed ID: 1282317
    [Abstract] [Full Text] [Related]

  • 5. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
    Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS.
    Neuropsychopharmacology; 2001 Oct 15; 25(4):468-75. PubMed ID: 11557160
    [Abstract] [Full Text] [Related]

  • 6. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H, Lindquist C, Sedvall G.
    Acta Neurochir (Wien); 1985 Oct 15; 77(3-4):146-51. PubMed ID: 2416192
    [Abstract] [Full Text] [Related]

  • 7. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May 15; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 8. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Vaughn DM, Smyth GB, Whitmer WL, Satjawatcharaphong C.
    Vet Res Commun; 1989 May 15; 13(3):237-49. PubMed ID: 2476887
    [Abstract] [Full Text] [Related]

  • 9. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct 15; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 10. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
    Wode-Helgodt B, Fyrö B, Gullberg B, Sedvall G.
    Acta Psychiatr Scand; 1977 Aug 15; 56(2):129-42. PubMed ID: 899844
    [Abstract] [Full Text] [Related]

  • 11. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF, Mohs RC, Davis KL.
    Psychiatry Res; 1984 May 15; 12(1):79-87. PubMed ID: 6205414
    [Abstract] [Full Text] [Related]

  • 12. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
    Lewine RR, Risch SC, Risby E, Stipetic M, Jewart RD, Eccard M, Caudle J, Pollard W.
    Am J Psychiatry; 1991 Sep 15; 148(9):1189-94. PubMed ID: 1715677
    [Abstract] [Full Text] [Related]

  • 13. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D.
    Arch Gen Psychiatry; 1993 Aug 15; 50(8):606-14. PubMed ID: 7688209
    [Abstract] [Full Text] [Related]

  • 14. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM, Lindström LH.
    Psychiatry Res; 1998 Nov 16; 81(2):101-10. PubMed ID: 9858027
    [Abstract] [Full Text] [Related]

  • 15. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H, MacDonald E, Rekonen M, Riekkinen PJ.
    Acta Neurol Scand; 1981 Aug 16; 64(2):101-7. PubMed ID: 6172950
    [Abstract] [Full Text] [Related]

  • 16. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M, Traskman-Bendz L, Dorovini-Zis K.
    Life Sci; 1985 Oct 07; 37(14):1279-86. PubMed ID: 2413327
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug 07; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL, Young SN, Garelis E, Lal S.
    Acta Vitaminol Enzymol; 1975 Aug 07; 29(1-6):97-9. PubMed ID: 1244132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.